Instead, arm yourself with the stats seen in these cool maps of Europe. After all ... Latvia at the highest of 15 per 1,000 people. On a scale set with 0 being "not satisfied at all" and 10 ...
Dr. Oliver Kessler (Lucerne University of Applied Sciences and Arts) and Dr. Clara Volintiru (Bucharest University of Economic Studies) – alongside leading experts in oncology policy: Dr. Bettina Ryll ...
In Eastern Europe, the projected revenue in the Oncology Drugs market is expected to reach US$1.84bn by 2024. The market is anticipated to exhibit an annual growth rate (CAGR 2024-2029 ...
The European Federation of Pharmaceutical Industries and Associations (EFPIA) asked the Medical Technology Research Group (MTRG) to conduct an evidence-based analysis to determine the use of ...
Jim Furniss and Chris Teale discuss the market access environment for new oncology products in Europe, including sales comparisons with the US and their thoughts on the future. What do we mean by ...
The projected revenue in the Oncology Drugs market for Northern Europe is expected to reach US$2.51bn in 2024. It is anticipated that the market will experience an annual growth rate (CAGR 2024 ...
Get global perspectives and insights from CEOs on the biggest stories in business. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
A new study from the Yale School of Public Health (YSPH) offers fresh insights into our understanding of colorectal cancer ...
Global developments and old challenges clash with the arrival of new technologies for drug development in oncology, creating both opportunities and obstacles for small biotech and big pharma.
The Molecular Analysis for Precision Oncology Congress 2024 (MAP) is the appointment where globally recognised experts will present and discuss research in precision medicine, technologies for cancer ...
Learn about our editorial policies In economics, the term diseconomies of scale describes the phenomenon that occurs when a firm experiences increasing marginal costs per additional unit of output.
The UAB Division of Gynecologic Oncology (GYN/ONC) serves as a major referral center for patients with gynecologic cancers in the state of Alabama, as well as the Southeast. We are a multidisciplinary ...